子皮干扰电流感官刺激对帕金森病患者吞功能的影响:单臂,开放标签研究协议
Masahiro Nakamori1, Megumi Toko1, Hidetada Yamada1
1Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Contemporary clinical trials communications
|June 21, 2023
概括
这项研究研究了对患有吞问题的帕金森病 (PD) 患者的皮肤干扰电流感官刺激. 治疗显示了改善吞功能的潜力,并减少PD的沉默渴望.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 经常导致吞功能障碍,增加吸入性肺炎的风险.
- 由于喉和喉的感觉减少,沉默的吸收是PD相关的重要吞问题.
研究的目的:
- 评估皮肤部干扰电流感官刺激对改善PD患者吞功能的有效性.
- 评估这种新刺激技术在患有PD的个体中的安全性和有效性.
主要方法:
- 这是一项单臂的开放性研究,涉及PD患者 (Hoehn-Yahr阶段2-4).
- 干预:20分钟的子皮干扰电流感官刺激,每周两次,持续8周.
- 评估包括使用酸进行咳反射测试,多通道表面电肌学和电子听力学.
主要成果:
- 这项研究旨在评估干预后咳反射正常的患者比例.
- 采用了新的仪器来全面评估吞功能.
结论:
- 穿皮干扰电流感官刺激可能为帕金森病的失消症提供新的治疗途径.
- 由于研究的探索性质,单臂设计和小样本大小,需要进一步的研究.
相关概念视频
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611


